Your browser doesn't support javascript.
loading
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.
Feng, Shuo; Phillips, Daniel J; White, Thomas; Sayal, Homesh; Aley, Parvinder K; Bibi, Sagida; Dold, Christina; Fuskova, Michelle; Gilbert, Sarah C; Hirsch, Ian; Humphries, Holly E; Jepson, Brett; Kelly, Elizabeth J; Plested, Emma; Shoemaker, Kathryn; Thomas, Kelly M; Vekemans, Johan; Villafana, Tonya L; Lambe, Teresa; Pollard, Andrew J; Voysey, Merryn.
Affiliation
  • Feng S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Phillips DJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • White T; Late-stage development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Sayal H; Late-stage development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Fuskova M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Gilbert SC; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Hirsch I; Late-stage development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Humphries HE; National Infection Service, Public Health England, Salisbury, UK.
  • Jepson B; Late-stage development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Kelly EJ; Cytel Inc., Cambridge, MA, USA.
  • Plested E; Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Shoemaker K; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Thomas KM; Late-stage development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Vekemans J; National Infection Service, Public Health England, Salisbury, UK.
  • Villafana TL; Late-stage development Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Lambe T; Late-stage development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Pollard AJ; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Voysey M; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.
Nat Med ; 27(11): 2032-2040, 2021 11.
Article in En | MEDLINE | ID: mdl-34588689
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunity, Humoral / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2021 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunity, Humoral / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2021 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos